CAS 540737-29-9 appears in our catalog under these names: Tofacitinib Citrate, Tofacitinib Citrate/ 99.75% (existing batch purity), Tofacitinib (CP–690550) Citrate, Tofacitinib citrate, 98.00%, Tofacitinib citrate 99%. Offered by: Chemat Brand, Mikromol, TargetMol, GLPBio, Biosynth. Available pack sizes: on request, 250mg, 5mg, 10mg, 50mg, 100mg, 200mg, 500mg.
Tofacitinib citrate is a citrate salt obtained by combining equimolar amounts of tofacitinib and citric acid. Used to treat moderately to severely active Rheumatoid Arthritis. It has a role as an antirheumatic drug and an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor. It contains a tofacitinib.
Source: ChEBI
| Molecular formula | C22H28N6O8 |
|---|---|
| Molecular weight | 504.5 g/mol |
| IUPAC name | 2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile |
| InChIKey | SYIKUFDOYJFGBQ-YLAFAASESA-N |
| SMILES | C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O |
Computed by PubChem (NCBI)